Sex differences in mutational rate and mutational mechanism in the NF1 gene in neurofibromatosis type 1 patients

Conxi Lázaro, Antonia Gaona, Peter Ainsworth, Romano Tenconi, Dominique Vidaud, Helena Kruyer, Elisabet Ars, Victor Volpini, Xavier P. Estivill

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder with a prevalence of around 1 in 3500, affecting all ethnic groups. The clinical manifestations of the disease are variable, even among members of the same family, and affect a variety of tissues and cell types, including skin, iris, central and peripheral nervous systems and skeletal system. It has been reported that the majority of sporadic mutations in NF1 arise in paternally inherited alleles. We present here a collaborative study of the parental origin and type of mutation in individuals with de novo NF1, who account for up to a half of all cases of clinically diagnosed NF1. We have studied intragenic and extragenic markers in 470 NF1 families. In 32 of these families it was possible to assess the parental origin of a de novo NF1 mutation either by linkage analysis (in families with three generations) or by the detection of an intragenic deletion in a sporadic NF1 case. Eleven of these 32 families have three generations (the second and third generation being affected), with the mutation (not a large deletion) being of paternal origin in 82% of them (P < 0.05). In the other 21 families an intragenic deletion was detected, in 76% being in the maternal chromosome and in 24% in the paternal one (P < 0.05). Our results suggest that in NF1 the majority of deletions occur in oogenesis, while other types of mutations should account for the paternally derived NF1 mutations.

Original languageEnglish
Pages (from-to)696-699
Number of pages4
JournalHuman Genetics
Volume98
Issue number6
DOIs
Publication statusPublished - Dec 1996
Externally publishedYes

Fingerprint

Neurofibromatosis 1 Genes
Neurofibromatosis 1
Sex Characteristics
Mutation
Oogenesis
Peripheral Nervous System
Iris
Ethnic Groups
Central Nervous System
Chromosomes
Alleles
Mothers

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Sex differences in mutational rate and mutational mechanism in the NF1 gene in neurofibromatosis type 1 patients. / Lázaro, Conxi; Gaona, Antonia; Ainsworth, Peter; Tenconi, Romano; Vidaud, Dominique; Kruyer, Helena; Ars, Elisabet; Volpini, Victor; Estivill, Xavier P.

In: Human Genetics, Vol. 98, No. 6, 12.1996, p. 696-699.

Research output: Contribution to journalArticle

Lázaro, C, Gaona, A, Ainsworth, P, Tenconi, R, Vidaud, D, Kruyer, H, Ars, E, Volpini, V & Estivill, XP 1996, 'Sex differences in mutational rate and mutational mechanism in the NF1 gene in neurofibromatosis type 1 patients', Human Genetics, vol. 98, no. 6, pp. 696-699. https://doi.org/10.1007/s004390050287
Lázaro, Conxi ; Gaona, Antonia ; Ainsworth, Peter ; Tenconi, Romano ; Vidaud, Dominique ; Kruyer, Helena ; Ars, Elisabet ; Volpini, Victor ; Estivill, Xavier P. / Sex differences in mutational rate and mutational mechanism in the NF1 gene in neurofibromatosis type 1 patients. In: Human Genetics. 1996 ; Vol. 98, No. 6. pp. 696-699.
@article{92b9c3210d5f4e98995708bbf3aa1579,
title = "Sex differences in mutational rate and mutational mechanism in the NF1 gene in neurofibromatosis type 1 patients",
abstract = "Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder with a prevalence of around 1 in 3500, affecting all ethnic groups. The clinical manifestations of the disease are variable, even among members of the same family, and affect a variety of tissues and cell types, including skin, iris, central and peripheral nervous systems and skeletal system. It has been reported that the majority of sporadic mutations in NF1 arise in paternally inherited alleles. We present here a collaborative study of the parental origin and type of mutation in individuals with de novo NF1, who account for up to a half of all cases of clinically diagnosed NF1. We have studied intragenic and extragenic markers in 470 NF1 families. In 32 of these families it was possible to assess the parental origin of a de novo NF1 mutation either by linkage analysis (in families with three generations) or by the detection of an intragenic deletion in a sporadic NF1 case. Eleven of these 32 families have three generations (the second and third generation being affected), with the mutation (not a large deletion) being of paternal origin in 82{\%} of them (P < 0.05). In the other 21 families an intragenic deletion was detected, in 76{\%} being in the maternal chromosome and in 24{\%} in the paternal one (P < 0.05). Our results suggest that in NF1 the majority of deletions occur in oogenesis, while other types of mutations should account for the paternally derived NF1 mutations.",
author = "Conxi L{\'a}zaro and Antonia Gaona and Peter Ainsworth and Romano Tenconi and Dominique Vidaud and Helena Kruyer and Elisabet Ars and Victor Volpini and Estivill, {Xavier P.}",
year = "1996",
month = "12",
doi = "10.1007/s004390050287",
language = "English",
volume = "98",
pages = "696--699",
journal = "Human Genetics",
issn = "0340-6717",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - Sex differences in mutational rate and mutational mechanism in the NF1 gene in neurofibromatosis type 1 patients

AU - Lázaro, Conxi

AU - Gaona, Antonia

AU - Ainsworth, Peter

AU - Tenconi, Romano

AU - Vidaud, Dominique

AU - Kruyer, Helena

AU - Ars, Elisabet

AU - Volpini, Victor

AU - Estivill, Xavier P.

PY - 1996/12

Y1 - 1996/12

N2 - Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder with a prevalence of around 1 in 3500, affecting all ethnic groups. The clinical manifestations of the disease are variable, even among members of the same family, and affect a variety of tissues and cell types, including skin, iris, central and peripheral nervous systems and skeletal system. It has been reported that the majority of sporadic mutations in NF1 arise in paternally inherited alleles. We present here a collaborative study of the parental origin and type of mutation in individuals with de novo NF1, who account for up to a half of all cases of clinically diagnosed NF1. We have studied intragenic and extragenic markers in 470 NF1 families. In 32 of these families it was possible to assess the parental origin of a de novo NF1 mutation either by linkage analysis (in families with three generations) or by the detection of an intragenic deletion in a sporadic NF1 case. Eleven of these 32 families have three generations (the second and third generation being affected), with the mutation (not a large deletion) being of paternal origin in 82% of them (P < 0.05). In the other 21 families an intragenic deletion was detected, in 76% being in the maternal chromosome and in 24% in the paternal one (P < 0.05). Our results suggest that in NF1 the majority of deletions occur in oogenesis, while other types of mutations should account for the paternally derived NF1 mutations.

AB - Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder with a prevalence of around 1 in 3500, affecting all ethnic groups. The clinical manifestations of the disease are variable, even among members of the same family, and affect a variety of tissues and cell types, including skin, iris, central and peripheral nervous systems and skeletal system. It has been reported that the majority of sporadic mutations in NF1 arise in paternally inherited alleles. We present here a collaborative study of the parental origin and type of mutation in individuals with de novo NF1, who account for up to a half of all cases of clinically diagnosed NF1. We have studied intragenic and extragenic markers in 470 NF1 families. In 32 of these families it was possible to assess the parental origin of a de novo NF1 mutation either by linkage analysis (in families with three generations) or by the detection of an intragenic deletion in a sporadic NF1 case. Eleven of these 32 families have three generations (the second and third generation being affected), with the mutation (not a large deletion) being of paternal origin in 82% of them (P < 0.05). In the other 21 families an intragenic deletion was detected, in 76% being in the maternal chromosome and in 24% in the paternal one (P < 0.05). Our results suggest that in NF1 the majority of deletions occur in oogenesis, while other types of mutations should account for the paternally derived NF1 mutations.

UR - http://www.scopus.com/inward/record.url?scp=0029969028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029969028&partnerID=8YFLogxK

U2 - 10.1007/s004390050287

DO - 10.1007/s004390050287

M3 - Article

VL - 98

SP - 696

EP - 699

JO - Human Genetics

JF - Human Genetics

SN - 0340-6717

IS - 6

ER -